Pharma reputation falls again, notching double-digit downturn over past year in US — survey
The pharma industry’s reputation continues to slip in the US as consumers pack away its pandemic hero status. The newest survey from The Harris Poll shows the industry at a 45% positive rating last month, down 10 percentage points from the same time last year.
While 45% is still above the just 32% pre-pandemic low that the industry held at beginning of 2020, it’s also notably lower than the 62% high point in February 2021. The 10-percentage point pharma drop since last fall is also the biggest decrease across all the industries that Harris Poll tracks, said managing director Rob Jekielek.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.